Rocket Pharmaceuticals (RCKT) Stock Price Target 2026

The average analyst price target for Rocket Pharmaceuticals is $8.77, 258.0% above the current price. Of 12 analysts, 8 rate it Buy, 3 Hold and 1 Sell. Targets range from $2.50 to $19. The latest change came on Oct 8, 2026, when Goldman Sachs upgraded Rocket Pharmaceuticals from Sell to Neutral and moved its price target from $3 to $4.